In general, these finding further illustrated that TINCR promoted HCC cells progression and resistance to oxaliplatin via the TINCR/miR-195-3p/ST6GAL1/ NF-κB signaling pathway (Fig. 6I). The gene discussed is TINCR; the disease is hepatocellular carcinoma.